Smale S, Tibble J, Bjarnason I
Department of Medicine, Guy's, King's, St. Thomas' Medical School, Bessemer Road, London, United Kingdom.
Curr Opin Gastroenterol. 2000 Mar;16(2):134-9. doi: 10.1097/00001574-200003000-00007.
The noninvasive assessment of small intestinal permeability in humans is now within the capability of any routine biochemistry laboratory. There remain however, many pitfalls for the unwary when performing these tests. Importantly, it has now been shown that normal intestinal permeability relates to geographical location rather than race. Recent studies show that it may be possible to simplify the procedure even further. The main recent focus of interest in measuring intestinal permeability relates to patients with AIDS and inflammatory bowel disease, the effects of nonsteroidal anti-inflammatory drugs on the small bowel, and the use of these tests in the pediatric population and critically ill. Some groups have now started to focus their attention on the possible systemic consequences of increased intestinal permeability, whereas others have shown that increased small bowel permeability results in small intestinal inflammation that may in turn be associated with blood and protein loss.
目前,对人体小肠通透性进行无创评估已成为任何常规生物化学实验室都能做到的事。然而,在进行这些检测时,粗心的人仍会面临许多陷阱。重要的是,现已表明正常的肠道通透性与地理位置有关,而非种族。最近的研究表明,甚至有可能进一步简化该程序。最近在测量肠道通透性方面的主要关注焦点涉及艾滋病患者和炎症性肠病患者、非甾体抗炎药对小肠的影响,以及这些检测在儿科人群和重症患者中的应用。一些研究小组现在已开始将注意力集中在肠道通透性增加可能产生的全身后果上,而另一些研究则表明,小肠通透性增加会导致小肠炎症,进而可能与血液和蛋白质流失有关。